Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lingfang Xia
Observed names:
L Xia,
L. Xia,
LINGFANG XIA,
Ling-fang Xia,
LingFang Xia,
Xia, Lingfang
show all 6
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Shanghai Jiao Tong University,
Fudan University,
Ruijin Hospital,
Fudan University Shanghai Cancer Center,
University of Benin,
Icahn School of Medicine at Mount Sinai
show all 7
ORCID:
0000-0002-4423-1615
Observed ORCID:
0000-0002-4423-1615
OpenAlex ID:
A5017078761
Programmed death ligand‐1 regulates angiogenesis and metastasis by participating in the c‐JUN/VEGFR2 signaling axis in ovarian cancer
2021
·
Yufei Yang
, Lingfang Xia
, et al.
·
癌症:英文版
·
66
Primary Malignant Melanoma of the Vagina
2013
·
Lingfang Xia
, Duo Han
, et al.
·
International Journal of Gynecological Cancer
·
54
A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study
2018
·
Zheng Feng
, Hao Wen
, et al.
·
Journal of Gynecologic Oncology
·
53
Predictive factors of para-aortic lymph nodes metastasis in cervical cancer patients: a retrospective analysis based on 723 para-aortic lymphadenectomy cases
2017
·
Xiaotian Han
, Hao Wen
, et al.
·
Oncotarget
·
47
PDF
Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket study
2022
·
Lingfang Xia
, Jin Peng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
39
PDF
Reproductive and obstetric outcomes after abdominal radical trachelectomy (ART) for patients with early-stage cervical cancers in Fudan, China
2020
·
Xiaoqi Li
, Lingfang Xia
, et al.
·
Gynecologic Oncology
·
36
A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma
2022
·
Lingfang Xia
, Qi Zhou
, et al.
·
Nature Communications
·
34
PDF
Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study
2023
·
Lingfang Xia
, Jing Wang
, et al.
·
International Journal of Gynecological Cancer
·
33
PDF
Oncological results and recurrent risk factors following abdominal radical trachelectomy: an updated series of 333 patients
2019
·
X Li
, J Li
, et al.
·
BJOG An International Journal of Obstetrics & Gynaecology
·
33
The Survival Rate and Surgical Morbidity of Abdominal Radical Trachelectomy Versus Abdominal Radical Hysterectomy for Stage IB1 Cervical Cancer
2016
·
Xiaoqi Li
, Jin Li
, et al.
·
Annals of Surgical Oncology
·
33
Simple conization and pelvic lymphadenectomy in early-stage cervical cancer: A retrospective analysis and review of the literature
2020
·
Xiaoqi Li
, Lingfang Xia
, et al.
·
Gynecologic Oncology
·
32
Validation of the prognostic value of various lymph node staging systems for cervical squamous cell carcinoma following radical surgery: a single‐center analysis of 3,732 patients
2020
·
Qinhao Guo
, Jun Zhu
, et al.
·
Annals of Translational Medicine
·
32
PDF
The feedback loop of AURKA/DDX5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer
2023
·
Yang Shao
, Hui Li
, et al.
·
Cancer Letters
·
30
Anti-tumor effect of polysaccharides from rhizome of Curculigo orchioides Gaertn on cervical cancer
2016
·
Ling-fang Xia
, Shan-hui Liang
, et al.
·
Tropical Journal of Pharmaceutical Research
·
30
PDF
PARP1-stabilised FOXQ1 promotes ovarian cancer progression by activating the LAMB3/WNT/β-catenin signalling pathway
2024
·
Jiangchun Wu
, Yong Wu
, et al.
·
Oncogene
·
27
PDF
m6A-modified circSTX6 as a key regulator of cervical cancer malignancy via SPI1 and IL6/JAK2/STAT3 pathways
2025
·
Xiaotian Han
, Lingfang Xia
, et al.
·
Oncogene
·
25
PDF
Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics Analyses
2020
·
Yong Wu
, Lingfang Xia
, et al.
·
Cancer Management and Research
·
25
PDF
Preoperative PET/CT score can predict complete resection in advanced epithelial ovarian cancer: a prospective study
2020
·
Bingxin Gu
, Lingfang Xia
, et al.
·
Quantitative Imaging in Medicine and Surgery
·
25
PDF
HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway
2021
·
Yong Wu
, Qinhao Guo
, et al.
·
Oncogene
·
24
PDF
Immune profiling reveals prognostic genes in high-grade serous ovarian cancer
2020
·
Yong Wu
, Lingfang Xia
, et al.
·
Aging
·
24
PDF
Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial
2021
·
Jun Zhu
, Chunyan Song
, et al.
·
Frontiers in Oncology
·
23
PDF
Comparison of different lymph node staging systems in patients with node-positive cervical squamous cell carcinoma following radical surgery
2020
·
Qinhao Guo
, Jun Zhu
, et al.
·
Journal of Cancer
·
22
PDF
Predictive value of preoperative serum squamous cell carcinoma antigen (SCC–Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study
2019
·
Qinhao Guo
, Jun Zhu
, et al.
·
European Journal of Surgical Oncology
·
22
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
2025
·
Lingfang Xia
, Keqiang Zhang
, et al.
·
Journal of Clinical Oncology
·
16
Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma via IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia
2021
·
Xiaotian Han
, Yechen Lu
, et al.
·
Frontiers in Oncology
·
16
PDF
Show more works
View as search
Works count:
47
Citation count:
882
H-index:
22
I10-index:
27
Year
Topic
Type